glp-1 blue cross blue shield Prime Therapeutics' leading research shows

Preclinical studies in animal models have suggested that some GLP-1 analogues may cross the blood-brain barrier, though the extent of this penetration in humans remains uncertain

Lowering your dose could make it harder to keep blood sugar levels in range, which is why Hatipoglu says dose reductions should be guided by a healthcare professional

Insulin and sulfonylureas may increase the chance of low blood sugar when combined with glucose-lowering therapy

Patients can inject themselves at home, which eliminates the need for frequent visits to a healthcare provider

Fan Z, Aman Y, Ahmed I, Chetelat G, Landeau B, Ray Chaudhuri K, et al

GLP-1s are gaining popularity in managing glucose levels and weight, but they may also have surprising benefits for skin health